Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype - Wikidata - wikimedia - TriplyDB

Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype

Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype

http://www.wikidata.org/entity/Q33894052

about

Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype Antioxidant Supplementation in the Treatment of Aging-Associated Diseases The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging Vitamins and type 2 diabetes mellitus Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.Genetic Variations Involved in Vitamin E Status The shifting perception on antioxidants: the case of vitamin E and β-carotene Oral High-Dose Multivitamins and Minerals After Myocardial Infarction Diabetic nephropathy and antioxidants.Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population Effect of Brown Rice Consumption on Inflammatory Marker and Cardiovascular Risk Factors among Overweight and Obese Non-menopausal Female Adults.Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.Nutrigenomics in human intervention studies: current status, lessons learned and future perspectives.The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.The effects of omega-3 plus vitamin E and zinc plus vitamin C supplementation on cardiovascular risk markers in postmenopausal women with type 2 diabetes.Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.The association of diabetes and dementia and possible implications for nondiabetic populations.Mitochondria: redox metabolism and dysfunction.Evaluation of haptoglobin genotypes in patients with metabolic syndrome: A preliminary report.Oxidative stress, insulin signaling, and diabetes.Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?Patient selection and vitamin E treatment in diabetes mellitus.An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype.Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection.Acute phase reactants as novel predictors of cardiovascular disease.Role of Haptoglobin in Health and Disease: A Focus on Diabetes.Vitamin E and diabetic nephropathy in mice model and humans.The changing face of young-onset diabetes: type 1 optimism mellowed by type 2 concerns.Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes.Concentrations of Water-Soluble Vitamins in Blood and Urinary Excretion in Patients with Diabetes Mellitus.Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer.Oxidative stress and cardiovascular health: therapeutic potential of polyphenols.Bioavailability of vitamin E in humans: an update.Changing the face of diabetic care with haptoglobin genotype selection and vitamin e.How to select the right cost-effectiveness model? : A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis.Vitamin E-drug interactions: molecular basis and clinical relevance.Hp: an inflammatory indicator in cardiovascular disease.Vitamin E Improves Serum Paraoxonase-1 Activity and Some Metabolic Factors in Patients with Type 2 Diabetes: No Effects on Nitrite/Nitrate Levels.THE SERUM PROTEIN FRACTIONS IN THYMOQUINONE TREATED RATS.The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications

P2860

Q24634553-DDCE4295-64F0-4EB5-A859-F8DCFFE01C4C Q26768165-8AE5AD80-313A-461A-BFCF-8F28E70E7F5F Q26864505-ED41D06F-802F-47E0-8F44-B74876D4FC2A Q27022122-8D2E668C-6696-468C-B38C-33A226E4A083 Q27332892-789CEB1E-5C20-47B0-A988-000D71E4A181 Q28071403-EC4958B1-7FFE-47FA-9F4F-AC746C00BDC2 Q28085597-C4BB5C77-8713-4AFB-AF49-B501997955F4 Q29012851-32D1EBA2-156F-4899-BE04-B72C1D58F361 Q30486658-AB94370E-E22A-4CA2-9559-A2F1C6A52AE1 Q33406987-E97D8052-0076-4A17-89FA-EA9026574CD7 Q33600673-8F2D56B6-F41F-469F-BB1C-1EF5A0F54CFE Q33718536-3D99AFEF-4EA2-4077-86F2-A587B52E2155 Q33807303-3E1582D2-546F-4F89-8ED9-B543C115A429 Q33965252-438BD4B5-7B21-411E-9550-CF1A33BDFAF0 Q34389300-1D80C90E-C40A-4EA4-8A31-9F9152E78C0E Q35596083-B640FEB8-8831-42D9-B1A2-814A75DA15ED Q35619553-DEB1C00A-E284-4542-8BC2-6611B2A085F7 Q35944831-4D3AEFD5-122A-43BA-BAE9-1EA23F12E551 Q36055337-989FF49D-F5B4-4B0E-A107-CCB000D90761 Q36570342-9327E68D-EFC1-48B5-9764-BEFD4D0A74AC Q36664118-EF21E762-B5E3-4D1B-BDB3-E24210F03F39 Q36736431-DD6BCA46-7FD6-489C-9103-D3FE855DF622 Q37029725-54982FCD-277D-4C6C-8397-AEB9690FB343 Q37076469-CBB5D194-C954-4EA0-9373-54666293CDCE Q37156874-0F04582E-A8EA-4734-95E6-2DC496D4ED0B Q37248191-34ADCA37-28F2-4562-8470-691CD914B1B2 Q37322007-C9695EED-30B5-4CCB-A12B-F021D4C32537 Q37331253-6DADE9A2-A87E-4362-A4A4-BCAE94D5E166 Q37385851-0D987E18-184B-43BB-8806-23158836BAC3 Q37387685-E34E2CA8-8E89-4E61-B639-9954529A4A50 Q37701536-DF0AAB6E-61A9-4158-B86A-B42DC8929E80 Q38093866-5217DD37-0FB5-4642-A558-7F60F1C86583 Q38111475-53879C43-E46D-4E9D-A447-79F97F4C2868 Q38126020-8E5670EB-9778-4B06-AC4D-2D667B4197DA Q38185992-C4D7D7FA-4A7E-4530-8CF4-8F7ACD20480B Q38250082-558513EE-D7F8-46FD-99D4-4667D56214F9 Q38864675-856C9054-17EC-4775-BE82-483183153E16 Q39990492-BF00C91B-B92A-454F-AB32-089F4120B2E7 Q41662503-DE3FA09A-2A1E-465D-9DB8-BAB379E0F21E Q42226832-B3BFBC06-2755-4244-B34E-42FEBC090E98

P2860

Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype

http://www.wikidata.org/entity/Q33894052

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vitamin E reduces cardiovascul ...... d the haptoglobin 2-2 genotype

@ast

Vitamin E reduces cardiovascul ...... d the haptoglobin 2-2 genotype

@en

type

label

Vitamin E reduces cardiovascul ...... d the haptoglobin 2-2 genotype

@ast

Vitamin E reduces cardiovascul ...... d the haptoglobin 2-2 genotype

@en

prefLabel

Vitamin E reduces cardiovascul ...... d the haptoglobin 2-2 genotype

@ast

Vitamin E reduces cardiovascul ...... d the haptoglobin 2-2 genotype

@en

P1433

Q33894052-3C6016AB-6C60-4366-94A6-13D6833D5D96

P1476

Q33894052-751C07DD-F35C-4569-9E13-64705CEC7711

P2093

Q33894052-2B371BD2-A41A-4104-A7B4-1855ECFC721A

Q33894052-2C6B60C1-D3F0-43E4-A483-60D9AA05AE00

Q33894052-5BC48977-E6FB-4D99-853B-AFF5F03E4BAF

Q33894052-7CF68255-D8F6-4F2A-9753-A4AB31A54E49

Q33894052-85A702EF-5A12-44F8-B92E-76811624513C

Q33894052-A24C94BB-E0D7-40B8-AAAD-7C6905B44B99

Q33894052-A603A03A-4A7D-469A-806C-60236CAA6C3A

Q33894052-B06E9EAE-4D64-4FBA-A022-D88669EB6E3A

Q33894052-BBA449E0-F25B-4AF1-BC0E-9F2A96E8C7CD

Q33894052-DBD575A4-8954-4783-A67B-9733239B299A

P2860

Q33894052-0D89293D-4BD0-4DAA-B77D-A14244CAC463

Q33894052-2416E908-7FF5-4007-B3C2-09CD94CBE2DB

Q33894052-257D403B-123A-4583-A041-A45209394E68

Q33894052-259CF49F-19D8-4C99-A88F-A1353FF2DF35

Q33894052-2A74969D-982F-4A93-BB7B-FE561DFFC144

Q33894052-3B1F0FAD-84CB-422C-A34A-14DD50CDE8C3

Q33894052-3F844C85-8824-4D26-8D7D-E84C554628A4

Q33894052-41074F12-59D4-4468-BACF-10E43766B5A0

Q33894052-42DBF29A-7F3F-4A07-B1C8-FC25525AA84B

Q33894052-4402FC58-896B-496A-84E7-02F260208622

P304

Q33894052-1EFEBA8D-79F0-4C1E-8FC3-2ABCB57237FD

P31

Q33894052-3960F63C-6B9E-4923-9A38-809CB75AE834

P356

Q33894052-D4B564F8-6ACA-4ECB-BD47-4B9DB283699C

P433

Q33894052-5B1F4054-BE50-43E4-B0E8-E81C539CBE24

P478

Q33894052-13FB4968-D0AE-4BD2-A833-C43DD4D7564F

P577

Q33894052-89F6FCBD-4B4B-4B02-823E-F29A58D3C66F

P5875

Q33894052-B8ED18EA-CCD0-43EB-AA95-FA3980974990

P698

Q33894052-2D89D673-295E-47A3-A812-11B88EA2909D

P921

Q33894052-633E67CC-1581-4C5F-B707-3924AC7ADD1C

P932

Q33894052-777F93BC-B263-4341-94C9-D955F778691C

P356

P1433

Pharmacogenomics

P1476

Vitamin E reduces cardiovascul ...... d the haptoglobin 2-2 genotype

@en

P2093

Allen Russell

http://www.w3.org/2001/XMLSchema#string

Andrew P Levy

http://www.w3.org/2001/XMLSchema#string

Chen Shapira

http://www.w3.org/2001/XMLSchema#string

Jonathan B Brown

http://www.w3.org/2001/XMLSchema#string

Moshe Vardi

http://www.w3.org/2001/XMLSchema#string

Nina S Levy

http://www.w3.org/2001/XMLSchema#string

Rabea Asleh

http://www.w3.org/2001/XMLSchema#string

Rachel Miller-Lotan

http://www.w3.org/2001/XMLSchema#string

Shany Blum

http://www.w3.org/2001/XMLSchema#string

Uzi Milman

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype.

Identification of the haemoglobin scavenger receptor.

Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.

P304

675-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.10.17

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43340115

http://www.w3.org/2001/XMLSchema#string

P698

20415560

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

2880717

http://www.w3.org/2001/XMLSchema#string